Log In
BCIQ
Print this Print this
 

Debio 0928

  Manage Alerts
Collapse Summary General Information
Company Debiopharm Group
DescriptionSmall molecule that inhibits interaction between RAF1 and retinoblastoma protein
Molecular Target CRAF (RAF1) ; Retinoblastoma protein
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/29/2009

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today